Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 35
Titolo Tipologia Data di pubblicazione Autori File
Use of IBD Drugs in Patients with Hepatobiliary Comorbidities: Tips and Tricks 01 - Articolo su rivista 2023 Massironi S.Mulinacci G.Palermo A.Invernizzi P. +
Exploring the spectrum of incidental gastric polyps in autoimmune gastritis 01 - Articolo su rivista 2023 Massironi S.Gallo C.Laffusa A.Invernizzi P. +
Paradoxical association between dyspepsia and autoimmune chronic atrophic gastritis: Insights into mechanisms, pathophysiology, and treatment options 01 - Articolo su rivista 2023 Invernizzi P.Massironi S. +
Incidence and prevalence of gastric neuroendocrine tumors in patients with chronic atrophic autoimmune gastritis 01 - Articolo su rivista 2023 Massironi S.Gallo C.Stegagnini M.Invernizzi P. +
Impact of metformin on the incidence of human cholangiocarcinoma in diabetic patients: A systematic review and meta-analysis 01 - Articolo su rivista 2023 Laffusa A.Ciaccio A.Gallo C.Invernizzi P.Massironi S. +
COVID-19 in patients with neuroendocrine neoplasms: two-year results of the INTENSIVE study 01 - Articolo su rivista 2023 Frassoni, SamueleBagnardi, VincenzoMassironi, Sara +
Sporadic and MEN1-related gastrinoma and Zollinger–Ellison syndrome: differences in clinical characteristics and survival outcomes 01 - Articolo su rivista 2023 Massironi S.Laffusa A.Invernizzi P. +
Any Role for Microbiota in Cholangiocarcinoma? A Comprehensive Review 01 - Articolo su rivista 2023 Laffusa A.Gallo C.Invernizzi P.Massironi S. +
Somatostatin analogs in patients with Zollinger Ellison syndrome (ZES): an observational study 01 - Articolo su rivista 2022 Massironi S.Invernizzi P. +
Rectal neuroendocrine tumors: Current advances in management, treatment, and surveillance 01 - Articolo su rivista 2022 Gallo C.Invernizzi P.Massironi S. +
Clinical challenge for gastroenterologists–Gastrointestinal manifestations of systemic mastocytosis: A comprehensive review 01 - Articolo su rivista 2022 Scaravaglio M.Pagni F.Ceola S.Invernizzi P.Massironi S. +
Clinical treatment of cholangiocarcinoma: an updated comprehensive review 01 - Articolo su rivista 2022 Laffusa, AliceScaravaglio, MikiCristoferi, LauraCiaccio, AntonioCortinovis, Diego LuigiInvernizzi, PietroMassironi, Sara +
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 99 - Altro 2022 Gerussi A.Carbone M.Invernizzi P.Crosignani A.D'Amato D.Fagiuoli S.Malinverno F.Mancuso C.Massironi S.Milani C.Ronca V.Strazzabosco M. +
Systematic review-Pancreatic involvement in inflammatory bowel disease 01 - Articolo su rivista 2022 Massironi, SaraVigano, ChiaraCristoferi, LauraInvernizzi, Pietro +
Intratumor Microbiome in Neuroendocrine Neoplasms: A New Partner of Tumor Microenvironment? A Pilot Study 01 - Articolo su rivista 2022 Massironi, SFacciotti, FInvernizzi, PMilione, M +
Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence? 01 - Articolo su rivista 2022 Massironi S.Gallo C.Scaravaglio M.Invernizzi P. +
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: Interim analysis of prospective ASPEN trial 01 - Articolo su rivista 2022 Massironi S.Invernizzi P. +
Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy 01 - Articolo su rivista 2021 Invernizzi P.Massironi S. +
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 01 - Articolo su rivista 2021 Fagiuoli S.Massironi S. +
Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies 01 - Articolo su rivista 2021 Invernizzi P.Massironi S. +
Mostrati risultati da 1 a 20 di 35
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile